<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Chinese population &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/chinese-population/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 13:45:32 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Chinese population &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Ovarian cancer discovery: targetable variant RAD51D found in Chinese patients</title>
		<link>https://bioengineer.org/ovarian-cancer-discovery-targetable-variant-rad51d-found-in-chinese-patients/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Wed, 21 Aug 2024 14:10:17 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[Chinese population]]></category>
		<category><![CDATA[Germline mutations]]></category>
		<category><![CDATA[Ovarian cancer]]></category>
		<category><![CDATA[PARP inhibitors]]></category>
		<category><![CDATA[RAD51D variant]]></category>
		<guid isPermaLink="false">https://bioengineer.org/ovarian-cancer-discovery-targetable-variant-rad51d-found-in-chinese-patients/</guid>

					<description><![CDATA[Researchers from BGI Genomics and Fudan University published new findings on OV among Chinese patients in JCO Global Oncology. The study revealed the germline mutational landscape of Chinese patients with OV and identified an enriched RAD51D variant in these patients. It further examined the functional implications of this Chinese-enriched RAD51D variant. This discovery can serve [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">231856</post-id>	</item>
	</channel>
</rss>
